{"references": ["Doudna, J.A.; Charpentier, E. Genome Editing. The New Frontier of Genome Engineering with CRISPR-Cas9. Science 2014, 346, 1258096.", "Chu, J.; Mir, A.; Gao, N.; Rosa, S.; Monson, C.; Sharma, V. ... & Sadler, K. C. A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. Disease models & mechanisms 2013, 6(1), 95- 105.", "Brasil, Sandra, Carlota Pascoal, Rita Francisco, Dorinda Marques-da-Silva, Giuseppina Andreotti, Paula A. Videira, and others, 'CDG Therapies: From Bench to Bedside', International Journal of Molecular Sciences, 19.5 (2018), 1\u201347. https://doi.org/10.3390/ijms19051304", "Clayton, P. T., and S. Grunewald, 'Comprehensive Description of the Phenotype of the First Case of Congenital Disorder of Glycosylation Due to RFT1 Deficiency (CDG In)', Journal of Inherited Metabolic Disease, 32.SUPPL. 1 (2009), 139\u201341. https://doi.org/10.1007/s10545-009-1108-x"]}

Resumen de la publicación de una participación en formato µVídeo en en el congreso Divulga NextGen (1ª edición) que se celebrará online, de manera gratuita y en las redes sociales los días 26, 27 y 28 de mayo de 2021.